Vilazodone for Corticosteroid-Induced Memory Impairment

Trial Profile

Vilazodone for Corticosteroid-Induced Memory Impairment

Phase of Trial: Phase II

Latest Information Update: 31 Mar 2015

At a glance

  • Drugs Vilazodone (Primary)
  • Indications Generalised anxiety disorder; Major depressive disorder; Social phobia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 25 Mar 2015 Status changed from active, no longer recruiting to completed,as reported by
    • 15 Apr 2014 Trial status changed from recruiting to active, no longer recruiting as reported by
    • 22 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top